MTE #32 Expanding the Donor Pool: Use of Hepatitis B Surface Antigen Positive Donors in Hepatitis B Seronegative Recipients (Ticketed)

Experts present information addressing the safety and efficacy of transplantation of HBsAg-positive donor organs into hepatitis B seronegative recipients and long-term management of hepatitis B post transplantation in this patient population. Topics include patient and graft survival, and posttransplant management including the role of hepatitis B immunoglobulin, long-term HBV suppressive managment, and HCC risk and surveillance.

MTE #15 Integrated Alcohol-Associated Liver Disease Clinics: How to Start and Lessons Learned (Ticketed)

Experts provide a primer on how to start, organize, and refine an integrated, multidisciplinary alcohol-associated liver disease (ALD) clinic. Topics addressed include creation of a business plan and troubleshooting potential pitfalls in running an integrated ALD clinic.  

MTE #22 Treating Alcohol Use Disorder in Patients with Alcohol-Associated Liver Disease (Ticketed)

Experts provide insights into the treatment of alcohol use disorder (AUD) in patients with alcohol-associated liver disease, with a focus on cirrhosis. Topics include the efficacy of FDA-approved therapeutics and off-label use of medications for AUD, and how to manage side effects of these agents. 

Hepatotoxicity and Pediatric Liver Disorders Special Interest Groups Joint Symposium, Part 1. Drug-Induced Liver Injury: Drug-Induced Liver Injury Across the Lifespan—Advances in Management

Topic experts discuss the risk of DILI and phenotypes of presentation from children to the elderly. Presenters review emerging and novel therapies associated with DILI, provide an update on blood-based biomarkers of DILI, and highlight research priorities to address knowledge gaps in this constantly evolving space.

Wait Wait...Don't DILI!

Join in the fun with the 3rd iteration of the popular (standing room only in 2024) and only (thank goodness) hepatotoxicity-themed game show at The Liver Meeting. The style and format of this workshop is loosely based on the NPR game show, &quot;Wait wait...Don&#39;t Tell Me!&quot;. The Hepatotoxicity Special Interest Group has assembled a panel of experts to address cutting-edge topics in DILI and mechanisms of hepatotoxicity. Speakers present in a &quot;speed data&quot; format, with the majority of time left for discussion and engagement with panelists and the audience. Speakers are introduced by ridiculous limericks anchored in the topic of the presentation rather than extensive CVs. The session features audience participation in a competition to win a unique AASLD Wait Wait...Don&#39;t DILI! mug.&nbsp;<br />
<br />
<strong>Slido:&nbsp;<a href="https://app.sli.do/event/wEwW966F9oGMuNmEr35rwh">https://app.sli.do/eve…;

American Association for the Study of Liver Diseases and Asian Pacific Association for the Study of the Liver Joint Symposium (AASLD/APASL): Acute-on-Chronic Liver Failure—Contrasting Perspectives From the East and West

Acute-on-chronic liver failure (ACLF) is the focus of this joint symposium from AASLD and the Asian Pacific Association for the Study of the Liver (APASL). ACLF is a complex syndrome characterized by acute hepatic decompensation in the setting of chronic liver disease leading to multiorgan failure and high short-term mortality. However, the definition, classification, and management strategies for ACLF vary significantly between APASL and AASLD guidelines. The program begins with an in-depth exploration of ACLF definitions as per APASL and AASLD, highlighting key clinical differences via case-based presentations. Expert discussions follow focusing on management strategies from both AASLD and APASL perspectives. While AASLD emphasizes early liver transplantation and intensive care, APASL advocates for aggressive medical management, including liver regeneration therapies. Understanding these distinct approaches is crucial for optimizing patient care, particularly in resource-limited settings.

First Timers Meet-Up

Welcome to your first experience of The Liver Meeting! Join us at the First Timer Meet-Up, a special event designed to welcome new attendees and help you make the most of your experience. This casual, friendly gathering is the perfect opportunity to:
<ul>
<li>Meet fellow first-time attendees from around the world.</li>
<li>Connect with esteemed AASLD members.&nbsp;</li>
<li>Learn how to navigate the meeting and optimize your time.</li>
<li>Ask questions and get insider tips.</li>
<li>Begin building your professional network in hepatology.</li>
</ul>
Whether you&#39;re a trainee, early-career professional, or new to the field, this event will help you feel at home and ready to dive into everything The Liver Meeting&reg; has to offer.

MTE #34 Updates in Sinusoidal Obstruction Syndrome and Veno-Occlusive Disease (Ticketed)

Join this interactive session that focuses on the diagnosis and management of sinusoidal obstruction syndrome and veno-occlusive disease. Topics include current diagnostic approaches for sinusoidal obstruction syndrome/veno-occlusive disease, available therapies, natural history of the condition, and patient prognosis.

American Association for the Study of Liver Diseases Guidelines: What's New in 2025

Prepared by the Practice Guidelines Committee, this session highlights newly published AASLD guidelines addressing critical issues regarding treatment of viral hepatitis B. Speakers also present an extensive list of topics pertaining to liver transplantation in adults ranging from pretransplant evaluation to management of various graft-related and nongraft-related postoperative complications.

Subscribe to